EdgarLookup

Turn Therapeutics Inc. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Turn Therapeutics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($1.90M) Nov 13, 2025
Q3 2025 Sep 30, 2024 ($666.4K) Nov 13, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($1.91M) Nov 13, 2025
Q3 2025 Sep 30, 2024 ($673.0K) Nov 13, 2025